Brain Cancer Trial, Recruiting NCT05947045 Sponsor: St. Jude Children's Research Hospital Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT05947045
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are starting radiation treatment for a brain tumor
  • People who are between 8 and 22 years old at the time of joining the trial
  • People whose primary language is English or Spanish
  • People (and one of their parents) who are willing to take part and give their agreement to participate, following the rules of the institution running the trial
  • People who are willing to take part in the required parts of a computer-based memory training program called Cogmed

Who may not be able to join:

  • People whose general intellectual ability, based on standardized testing, is estimated to be significantly below average (an IQ score below 70)
  • People who have a history of a significant brain or nervous system condition before their brain tumor diagnosis, such as a stroke or a head injury that caused loss of consciousness
  • People who have a major physical impairment — such as blindness, significant muscle weakness, poorly controlled seizures, or difficulty sitting or standing without help — that would prevent them from completing the cognitive (thinking and memory) tests or training in the study
  • People who have a mental health condition that would prevent or take priority over taking part in the study, such as active psychosis or thoughts of suicide
  • People who need to be put under full general anesthesia during their daily radiation treatment sessions (note: people who only need sedation during the planning stage of radiation, but not during the daily treatments themselves, may still be eligible — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andrew Heitzer, PhD, ABPP-CN, St. Jude Children's Research Hospital

Phone: 888-226-4343

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
St. Jude Children's Research Hospital
Registry
ClinicalTrials.gov
Start date
22 June 2023
Est. completion
1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Participation Rate; Adherence; Side Effects

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov